うつ病治療薬の世界市場2015-2019...市場調査レポートについてご紹介

【英文タイトル】Global Depression Drugs Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market overview
03.2 Product offerings

04.Product Profiles
04.1.1 Celexa
04.1.2 Fetzima
04.1.3 Lexapro
04.1.4 Viibryd
04.1.5 Cymbalta
04.1.6 Prozac
04.1.7 Symbyax
04.1.8 Paxil
04.1.9 Wellbutrin
04.1.10 Abilify
04.1.11 Effexor
04.1.12 Pristiq
04.1.13 Zoloft

05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology

06.Introduction

07.Disorder Overview
07.1 Types of depression
07.1.1 Major depressive disorder
07.1.2 Persistent depressive disorder
07.1.3 Psychotic depression
07.1.4 Postpartum depression
07.1.5 Seasonal affective disorder
07.1.6 Bipolar disorder
07.2 Etiology
07.3 Epidemiology
07.3.1 Bipolar disorder among adults
07.3.2 Dysthymic disorder among adults
07.3.3 Major depression among adults
07.3.4 Major depression among adolescents
07.4 Treatment and management
07.5 Economic burden

08.Market Landscape
08.1 Market overview
08.2 Market size and forecast
08.3 Depression drugs market in US 2014-2019
08.3.1 Market size and forecast
08.4 Five forces analysis

09.Market Segmentation by Mechanism of Action

10.Geographical Segmentation
10.1 Segmentation of global depression drugs market by geography 2014

11.Pipeline Portfolio
11.1 Key information on late-stage pipeline molecules
11.1.1 Brexpiprazole
11.1.2 ALKS 5461
11.1.3 Cariprazine
11.1.4 TGFK07AD

12.Buying Criteria

13.Market Growth Drivers

14.Drivers and their Impact

15.Market Challenges

16.Impact of Drivers and Challenges

17.Market Trends

18.Trends and their Impact

19.Vendor Landscape
19.1 Competitive scenario
19.1.1 Key news
19.1.2 Mergers and acquisitions
19.2 Market share analysis 2014
19.2.1 Competitive assessment of top drugs used for treating depression
19.2.2 Bristol-Myers Squibb
19.2.3 Eli Lilly
19.2.4 Pfizer
19.2.5 GlaxoSmithKline
19.2.6 Actavis
19.3 Other and future prominent vendors

20.Key Vendor Analysis
20.1 Actavis
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation
20.1.4 Business Segmentation by Revenue 2012 and 2013
20.1.5 Geographical segmentation by Sales 2013
20.1.6 Business Strategy
20.1.7 Recent Developments
20.1.8 SWOT Analysis
20.2 Bristol-Myers Squibb
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Key Product Offerings
20.2.4 Revenue by Geography
20.2.5 Business Strategy
20.2.6 Key Information
20.2.7 SWOT Analysis
20.3 Eli Lilly
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation by Revenue
20.3.4 Sales by Geography
20.3.5 Business Strategy
20.3.6 Key Information
20.3.7 SWOT Analysis
20.4 GlaxoSmithKline
20.4.1 Key facts
20.4.2 Business overview
20.4.3 Business segmentation by revenue 2014
20.4.4 Business segmentation by revenue 2013 and 2014
20.4.5 Geographical segmentation by revenue 2014
20.4.6 Business strategy
20.4.7 Recent developments
20.4.8 SWOT analysis
20.5 Pfizer
20.5.1 Key facts
20.5.2 Business overview
20.5.3 Business segmentation by revenue 2014
20.5.4 Business segmentation by revenue 2013 and 2014
20.5.5 Geographical segmentation by revenue 2014
20.5.6 Business strategy
20.5.7 Key developments
20.5.8 SWOT analysis

21.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: NIMH classification of depression
Exhibit 3: Prevalence data for major depressive disorder among adults in US (2012)
Exhibit 4: Prevalence data for dysthymic disorder among adults in US (2012)
Exhibit 5: 12-month prevalence data for major depressive disorder with severe impairment among adults in US (2012)
Exhibit 6: Prevalence data for major depressive disorder among adults in US (2012)
Exhibit 7: Prevalence data for major depression among adults in US (2012)
Exhibit 8: WHO guidelines for management of depression
Exhibit 9: Economic burden of depression in US
Exhibit 10: Segmentation of costs associated with depression
Exhibit 11: Snapshot of economic burden of depression in US
Exhibit 12: Global depression drugs market 2014-2019 ($ millions)
Exhibit 13: Depression drugs market in US 2014-2019 ($ millions)
Exhibit 14: Segmentation of global depression drugs market by mechanism of action
Exhibit 15: Segmentation of global depression drugs market by mechanism of action 2014
Exhibit 16: Segmentation of global depression drugs market by geography 2014
Exhibit 17: Depression drugs: pipeline portfolio
Exhibit 18: Vendor ranking 2014
Exhibit 19: YoY growth rate of major depression drugs 2010-2014 ($ millions)
Exhibit 20: Revenue comparison of top drugs used for treating depression in 2013 ($ millions)
Exhibit 21: YoY global revenue of Abilify 2010-2014 ($ millions)
Exhibit 22: YoY global revenue of Cymbalta 2010-2014 ($ millions)
Exhibit 23: YoY global revenue of Pristiq 2010-2014 ($ millions)
Exhibit 24: YoY global revenue of Zoloft 2010-2014 ($ millions)
Exhibit 25: YoY global revenue of Effexor 2010-2014 ($ millions)
Exhibit 26: YoY global revenue of Wellbutrin 2010-2013 ($ millions)
Exhibit 27: YoY revenue of Wellbutrin in US 2010-2013 ($ millions)
Exhibit 28: YoY global revenue of Paxil 2010-2014 ($ millions)
Exhibit 29: Actavis: Business Segmentation
Exhibit 30: Actavis: Business Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 31: Actavis: Geographical segmentation by Sales 2013
Exhibit 32: Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas)
Exhibit 33: Bristol-Myers Squibb Co.: Revenue by Geographical Segmentation 2013
Exhibit 34: Eli Lilly: Business Segmentation by Revenue 2013
Exhibit 35: Eli Lilly: Business Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 36: Eli Lilly: Sales by Geography 2013
Exhibit 37: GlaxoSmithKline: Business segmentation by revenue 2014
Exhibit 38: GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billion)
Exhibit 39: GlaxoSmithKline: Geographical segmentation by revenue 2014
Exhibit 40: Pfizer: Business segmentation by revenue 2014
Exhibit 41: Pfizer: Business segmentation by revenue 2013 and 2014 ($ billion)
Exhibit 42: Pfizer: Geographical segmentation by revenue 2014


【レポート販売概要】

■ タイトル:うつ病治療薬の世界市場2015-2019
■ 英文:Global Depression Drugs Market 2015-2019
■ 発行日:2015年6月10日
■ 調査会社:Technavio
■ 商品コード:IRTNTR6053
■ 調査対象地域:グローバル
  • バイオインフォマティクス(生命情報学)の世界市場
    About Bioinformatics Bioinformatics is a field of science that includes computational analysis of biological data, which consists of information stored in DNA form and protein sequences in various biological databases. Biology, information technology, and computer science merge into single discipline in bioinformatics. This field is deep rooted in molecular biology and surrounds subject areas from …
  • プロ用ヘアケア製品の世界市場:ヘアカラー、シャンプー、コンディショナー、ヘアスタイリング製品
    About Professional Hair Care Professional hair care products are advanced products recommended by experts and made for specific consumer needs based on type of hair, to cleanse and enhance its texture and quality. These products offer solutions for hair- and scalp-related issues such as hair loss, dandruff, hair damage, hair thinning, split ends, and scalp itch. Professional hair care products suc …
  • 医療産業における認知評価・トレーニングの世界市場予測(~2021年)
    MarketsandMarkets forecasts the cognitive assessment and training in healthcare market size to grow from USD 962.0 Million in 2016 to USD 4,127.2 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 33.8%. Major factors contributing to the growth of the market include aging global population, increasing awareness about brain fitness, and advancements in technology. These factors will drive …
  • Nordic Storage AB:石油・ガスバリューチェーン分析レポート2013
    Nordic Storage AB Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Nordic Storage AB" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Nordic Storage AB”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the …
  • 飼料用プレミックスの世界市場:ビタミン、ミネラル、 アミノ酸、抗生物質
    In order to cater to the demands for quality meat with increasing meat consumption across the globe, animal breeders are focusing to boost animal health and their nutritious diet. Feed premixes are consequently seen as those products that can improve the return on investments. Premixes perform the essential role of improving feed nutritional value and performance of animals, while preventing them …
  • Alpha-Pyrrolidoneの世界市場
    Alpha-Pyrrolidone (CAS 616-45-5) Market Research Report 2013 presents comprehensive data on alpha-pyrrolidone markets globally and regionally (Europe, Asia, North America etc.) The report includes alpha-pyrrolidone description, covers its application areas and related patterns. It overviews alpha-pyrrolidone market, names alpha-pyrrolidone producers and indicates its suppliers. Besides, the report …
  • 地形認識警報装置(TAWS)の世界市場予測(~2022年)
    “TAWS market is estimated to grow at a CAGR of 5.8% between 2016 and 2022”According to the new market research report on TAWS, this market is expected to be worth USD 253.0 million by 2022, growing at a CAGR of 5.8% between 2016 and 2022. The growth of this market can be attributed to increase in the number of fleet, paradigm shift from rail/road transport to air transport, and mandate to install …
  • フェノール・ホルムアルデヒドのグローバル市場動向2011-2016(Phenol-Formaldehyde (PF) – A Global Market Watch, 2011 – 2016)
    Global Market Watch: With a CAGR of 12.1%, global volume market value for Phenol-Formaldehyde (PF) market is projected to reach 16 million tons by 2016, respectively. On a global scale, Asia-Pacific accounts for more than 30% of the market share followed by the Americas and Europe for the analysis period 2011-2016. While US accounts for the highest share of the global volume market on a regional c …
  • 黄斑浮腫(Macular Edema):世界の治験レビュー(2015年上半期版)
    Macular Edema Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Macular Edema Global Clinical Trials Review, H1, 2015" provides data on the Macular Edema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Macular Edema. It includes an overview of the trial numbers and their recruitment status as per the …
  • 中国の再生可能エネルギー市場分析:Analyzing Renewable Energy in China
    China’s rapid economic growth and heavy reliance on increasingly expensive foreign oil, the vast environmental toll that is one of the most apparent costs of China's economic success, persistent rural poverty in China and periodic power shortages all have impressed upon the Chinese government that renewable energy must be a large part of China's economy if China is to both complete its economic tr …
  • Acute Renal Failure (ARF) (Acute Kidney Injury):グローバル臨床試験レビューH2, 2013
    Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2013" provides data on the Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trial scenario. This report provides elemental information and data relating to the clinical trials …
  • 世界のビックデータ市場:Global Big Data Market 2014-2018
    TechNavio's analysts forecast the Global Big Data market to grow at a CAGR of 34.17 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need to upgrade business processes and improve productivity. The Global Big Data market has also been witnessing the increase in market consolidation. However, the lack of awareness about the potential of big data co …
  • 世界の振動監視装置市場2015
    The Global Vibration Monitoring Equipment Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Vibration Monitoring Equipment industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Vibration Monitoring Equipment market analysis is provided for the internati …
  • 世界のスズ市場:市場規模、動向、メーカー動向
    Scope The report presents a thorough study of tin, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing tin production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: tin production in the c …
  • 生体フォトニクス技術の世界市場:バイオイメージング、バイオアッセイ、光学バイオセンサ、バイオチップ、医療機器
    The global biophotonics market is expected to reach USD 50.18 Billion by 2020 from USD 26.26 Billion in 2014, at a CAGR of 11.5% from 2015 to 2020. This market is primarily driven by the emergence of nanotechnology, significant technological advancements, increasing demand for home-based POC devices, aging population, and growing lifestyle diseases. Biophotonics technologies enable better imaging …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。